Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/122654

Beta release

Statistics of Re: Dugel et al: HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration (Ophthalmology. 2019 Apr 12 [Epub ahead of print]) Reply
Statistics for this year
PeriodVisitsDownloads
202600
Statistics for the last 3 months
PeriodVisitsDownloads
2026-0400
2026-0500
2026-0600